[HTML] from nih.govS Pathak, E Goldofsky, EX Vivas… - The Journal of …, 2011 - Am Assoc Immnol Autoimmune inner ear disease is an enigmatic disorder characterized by recurring episodes of sudden or progressive sensorineural hearing loss. Hearing loss can be improved by timely corticosteroid administration, but only half of those treated respond, and for many ... Related articles - All 5 versions
NC Huang… - Otology & Neurotology, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Objective: To determine the response to ... Related articles - All 4 versions
WJ Kong, DY Wang, X Huang… - Acta Oto- …, 2011 - informahealthcare.com Conclusion: A better animal model of autoimmune inner ear disease (AIED) in Sprague-Dawley rats has been developed by combination with high dose of pertussis toxin. This study also indicated that inner ear-specific antigens can be involved in autoimmune reactions. Cell-mediated ... Related articles - All 3 versions
M Dettmer, I Hegemann… - Audiology and …, 2011 - content.karger.com Patients with autoimmune inner ear disease develop rapidly progressive sensorineural hearing loss over a period of several weeks or months, often accompanied by vestibular loss. This disease can occur as a distinct clinical entity or in association with an underlying autoimmune ... Cited by 1 - Related articles - All 3 versions
[HTML] from nih.govHK Cho, YJ Lee, JH Chung… - Clinical and Experimental …, 2011 - ncbi.nlm.nih.gov ... discontinuation of steroids (3, 4). In cases of autoimmuneinnereardisease, maintenance dose is continued for a variable time but the patients with treatment duration of fewer than 6 months are at increased risk of relapse compared with those treated for 6 months or longer. ... Related articles - All 8 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
